NORCROSS, Ga. -- Regent Medical Americas, the North American arm of Regent Medical Ltd., announces completion of Regent Medical Ltds merger with MÃ¶lnlycke Health Care and Medlock Medical, creating a leading medical products group, MÃ¶lnlycke Health Care Group, with a strong brand focus.Â
According to Lundy Fields, formerly Regent Medical Americas president and now MÃ¶lnlycke Health Care U.S. president, the merger of Gothenburg, Sweden-based MÃ¶lnlycke Health Care with two Manchester, United Kingdom-based companies (Regent Medical and Medlock Medical), results in a new force in global healthcare. The compelling strategic fit between MÃ¶lnlycke and Regent, a leading surgical supplier known for its two brands BiogelÂ® powder-free surgical gloves and HIBICLENSÂ® antiseptic/antimicrobial skin cleanser, and Medlock, a niche wound care company, creates a company with a significantly enhanced product range and opportunity in the market, Fields said.
The companys two strategic divisions will be Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division will encompass a leading manufacturer and supplier of powder-free surgical gloves (BiogelÂ® surgical gloves) and a leading supplier of skin cleanser (HibiclensÂ® and HibistatÂ® antiseptics). A leader in trauma and pain management, the Wound Care Divisions market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.Â
There are clear synergies between the companies in terms of sales force and distribution as well as in R&D; this, together with a more decentralized approach by management, will see the opportunities for cost savings, increased profitability and an accelerated top line growth.
Commenting on the new strategy, MÃ¶lnlycke CEO John Samuel said, The platform for future growth is in place and now it is time for us to focus on improving and expanding our business. Our strategy is two-fold: In Surgical, we plan to take advantage of the growing market need for single use products and further expand geographically; and in Wound Care, we plan to grow the advanced wound care business from the strong base of the market leading SafetacÂ® technology both with innovative new products and further geographical spread.